News
Positivre Strand RNA viruses 2019
Combination therapy of tumors
Since it is common practice to combine irradiation of tumours in humans with drug treatment we have developed procedures that works on nude mice xenotransplanted with human tumour cells. The figure below shows an example in which HCT116/GFP tumours responded to...
read moreKanceras HDAC6-projekt tilldelas anslag från Vinnova
Pressmeddelande Stockholm 2015-06-12 Kanceras HDAC6-projekt tilldelas anslag från Vinnova Kancera har av Sveriges innovationsmyndighet VINNOVA tilldelats ett anslag om totalt 2,000,000 kronor riktat till projekt som kan utvecklas till nya starka innovationer....
read moreThe true value of a good partnership!
Urban Hoglund met Ari Tolonen, who is the CEO of Admescope, at the Nordic Life Science Day event in 2012. Admescope is a Finnish CRO that provides Bioanalytical services as part of their broad ADME-Tox service offering. The value of finding the right...
read moreAdlego is testing OsteoDex in an in-vivo model of breast cancer!
Adlego is testing OsteoDex in an in-vivo model of breast cancer and you can read more in the link below. https://www.aktietorget.se/NewsItem.aspx?ID=73302
read moreDrugs for treatment of colorectal cancer, identified with use of three-dimensional cell culture-based screening, was validated in-vivo by Adlego!
Drugs for treatment of colorectal cancer, identified with use of three-dimensional cell culture-based screening, was validated in-vivo by Adlego. http://www.ncbi.nlm.nih.gov/pubmed/25911689
read moreSuccessful LÄKEMEDELSEVENTET 2015!
On Wednesday 22nd April in the afternoon, Adlego Biomedical were part of the Läkemedelseventet 2015. About 50 delegates were present who enjoyed listening to presentations about alternative and innovative solutions to advance the development of potential new...
read moreIs There a Need for Virtual Pre-clinical CROs (vCRO) to Support the Life Science Industry?
Pharma companies need in-vivo pharmacology and toxicology supplied by professionals. Virtual contract research organisations might be the future of drug development partnerships. But what does a vCRO CEO think about this? Is there a need for virtual pre-clinical CROs...
read moreInvitation to LÄKEMEDELSEVENTET 2015!
Adlego would like to invite you to a exciting afternoon at the the Läkemedelseventet 2015, which is to be held on 22nd April at 14.00 in Grev Turegatan 16 (IVA), Stockholm. We look forward to seeing you there!
read moreOur start to 2015!
As usual, the beginning of year 2015 has been busy catching up with documentation and finalising reports from the studies performed at end of the 2014. We were also very busy with a number of PK studies in rabbits of a well-known drug which is now to be developed for...
read more